Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation and NovaScan, Inc., a company that develops breakthrough technology for...
Veracyte, Inc., a leading cancer diagnostics company, announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities...
Catching cancer earlier and achieving more accurate initial diagnostics are two of the key benefits of breakthrough artificial intelligence technology that a European company...
